Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 244

    2.

    Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study.

    Chan WM, Lai TY, Wong AL, Liu DT, Lam DS.

    Br J Ophthalmol. 2007 Feb;91(2):174-9. Epub 2006 Sep 20.PMID: 16987898 [PubMed - indexed for MEDLINE]Related articles

    3.

    Triamcinolone acetonide as adjunctive treatment to verteporfin in neovascular age-related macular degeneration: a prospective randomized trial.

    Chaudhary V, Mao A, Hooper PL, Sheidow TG.

    Ophthalmology. 2007 Dec;114(12):2183-9.PMID: 18054638 [PubMed - indexed for MEDLINE]Related articles

    4.

    Photodynamic therapy with intravitreal triamcinolone in predominantly classic choroidal neovascularization: one-year results of a randomized study.

    Arias L, Garcia-Arumi J, Ramon JM, Badia M, Rubio M, Pujol O.

    Ophthalmology. 2006 Dec;113(12):2243-50. Epub 2006 Sep 25.PMID: 16996600 [PubMed - indexed for MEDLINE]Related articles

    5.

    Combined photodynamic therapy and intravitreal triamcinolone for neovascular age-related macular degeneration: effect of initial visual acuity on treatment response.

    Schadlu R, Kymes SM, Apte RS.

    Graefes Arch Clin Exp Ophthalmol. 2007 Nov;245(11):1667-72. Epub 2007 Jun 22.PMID: 17583819 [PubMed - indexed for MEDLINE]Related articles

    6.

    Triple therapy for neovascular age-related macular degeneration using single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone.

    Yip PP, Woo CF, Tang HH, Ho CK.

    Br J Ophthalmol. 2009 Jun;93(6):754-8. Epub 2009 Mar 8.PMID: 19273471 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Photodynamic therapy and high-dose intravitreal triamcinolone to treat exudative age-related macular degeneration: 1-year outcome.

    Ruiz-Moreno JM, Montero JA, Barile S, Zarbin MA.

    Retina. 2006 Jul-Aug;26(6):602-12.PMID: 16829800 [PubMed - indexed for MEDLINE]Related articles

    10.

    Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration.

    Augustin AJ, Schmidt-Erfurth U.

    Am J Ophthalmol. 2006 Apr;141(4):638-45.PMID: 16564797 [PubMed - indexed for MEDLINE]Related articles

    11.

    Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomised, controlled clinical study.

    Weigert G, Michels S, Sacu S, Varga A, Prager F, Geitzenauer W, Schmidt-Erfurth U.

    Br J Ophthalmol. 2008 Mar;92(3):356-60.PMID: 18303156 [PubMed - indexed for MEDLINE]Related articles

    12.

    Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization.

    Spaide RF, Sorenson J, Maranan L.

    Ophthalmology. 2003 Aug;110(8):1517-25.PMID: 12917166 [PubMed - indexed for MEDLINE]Related articles

    14.

    Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization.

    Spaide RF, Sorenson J, Maranan L.

    Ophthalmology. 2005 Feb;112(2):301-4.PMID: 15691567 [PubMed - indexed for MEDLINE]Related articles

    15.

    Intravitreal bevacizumab (Avastin) in combination with verteporfin photodynamic therapy for choroidal neovascularization associated with age-related macular degeneration (IBeVe Study).

    Costa RA, Jorge R, Calucci D, Melo LA Jr, Cardillo JA, Scott IU.

    Graefes Arch Clin Exp Ophthalmol. 2007 Sep;245(9):1273-80. Epub 2007 Feb 28.PMID: 17333238 [PubMed - indexed for MEDLINE]Related articles

    16.

    [Photodynamic therapy in age-related macular degeneration--results of one year observation]

    Wykrota H, Gierek-Łapińska A.

    Klin Oczna. 2002;104(3-4):239-43. Polish. PMID: 12608309 [PubMed - indexed for MEDLINE]Related articles

    17.

    Combined photodynamic therapy and intravitreal triamcinolone acetonide injection for neovascular age-related macular degeneration with pigment epithelium detachment.

    Axer-Siegel R, Ehrlich R, Avisar I, Kramer M, Rosenblatt I, Priel E, Weinberger D.

    Ophthalmic Surg Lasers Imaging. 2006 Nov-Dec;37(6):455-61.PMID: 17152538 [PubMed - indexed for MEDLINE]Related articles

    18.

    Photodynamic therapy and high-dose intravitreal triamcinolone to treat exudative age-related macular degeneration: 2-year outcome.

    Ruiz-Moreno JM, Montero JA, Zarbin MA.

    Retina. 2007 Apr-May;27(4):458-61.PMID: 17420698 [PubMed - indexed for MEDLINE]Related articles

    19.

    Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration.

    Augustin AJ, Schmidt-Erfurth U.

    Ophthalmology. 2006 Jan;113(1):14-22. Epub 2005 Dec 19.PMID: 16360209 [PubMed - indexed for MEDLINE]Related articles

    20.

    Effect of posterior juxtascleral triamcinolone acetonide on the efficacy and choriocapillaris hypoperfusion of photodynamic therapy.

    Iriyama A, Obata R, Inoue Y, Takahashi H, Tamaki Y, Yanagi Y.

    Graefes Arch Clin Exp Ophthalmol. 2008 Mar;246(3):339-44. Epub 2007 Sep 6.PMID: 17805556 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data